News

With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...
Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...
Viking's 40% crash over fixable dosing issues ignores its best-in-class 12.2% oral weight loss and Phase 3 momentum.
The unnamed 67-year-old man from Israel had been prescribed Semaglutide to treat his type 2 diabetes and also to help him lose weight .
A groundbreaking final stage trial showed users could lose more than 10 per cent of their weight after just over a year on ...
Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued International Stocks According to Analysts. On August 19, TD Cowen ...
The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday. Lilly, ...
New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight.
An embattled Iowa telepharmacy owner, fined $25,000 for selling fake Ozempic, says he didn't know the weight-loss drug was counterfeit ...
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...